Please provide your email address to receive an email when new articles are posted on . “Open gastrectomy has long been the criterion standard worldwide. However, application of laparoscopic ...
A phase I/IIa open label, nonrandomized, multicenter study of CYNK-101 in combination with trastuzumab and pembrolizumab in patients with locally advanced unresectable or metastatic HER2-positive ...
Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback